Background: Fluid collection (FC) of lymph or blood may accumulate at the site of excision after surgery for soft tissue sarcoma, with reported incidence rates from 10% to 36%. The purpose of this study is to analyze the impact of FC on local recurrence (LR) and wound complication rates after adjuvant postoperative radiotherapy (PORT) in lower extremity soft tissue sarcoma (LE-STS). Methods: Eighty-eight patients diagnosed with LE-STS were curatively treated with wide excision and PORT. FC developed in 51.1% of patients. Full FC volumes were included in the irradiation field throughout the full course of PORT for 36 patients (80.0%). A median of 61.2 and 63 Gy was prescribed for patients with and without FC, respectively. Results: After a median follow-up of 4.3 years, patients with and without FC had 5-year local control rates of 77.7% and 90.8% (P = 0.105). Eight patients with FC had LR, of which six patients had recurrent tumors at or within 4 cm of the FC wall and three of these patients had out-of-field LR. Wound complication occurred after RT in 3 (6.7%) of 45 patients with FC and 1 (2.3%) of 43 patients without FC. Conclusions: FC presents a potential risk for increased LR, particularly near the FC wall. Based on reasonable wound complication rates, we suggest the need and feasibility of fully including FC volumes in the irradiation field.
Introduction
Soft tissue sarcomas (STS) are a heterogeneous group of malignancies originating from mesenchymal cells. Wide excision with preoperative or postoperative radiotherapy (PORT) is the treatment of choice, demonstrating local control (LC) and survival rates that are comparable to that of amputation or radical excision while allowing limb salvage and function preservation (1) (2) (3) . Fluid collection (FC) of lymph or blood at the site of excision is a relatively common observation, with incidence rates of 10-36% (4) (5) (6) (7) (8) (9) . Documentation of FC is limited and includes data predating MR imaging; detection rates are likely to be higher with modern-day imaging techniques.
The dilemma with FC with respect to PORT is whether this volume should be included in the irradiation field. STS has a high likelihood of local recurrence (LR), thus requires aggressive local treatment. Relatively large PORT fields are mandated for improved LC based on potential microscopic tumor spread up to 4 cm beyond the surgical bed (10, 11) . Micrometastasis generally occurs longitudinally within anatomical boundaries because STS tend to 'push against' rather than directly invade adjacent tissues. Radiation Therapy Oncology Group recommends a 3 cm longitudinal and 1.5 cm radial expansion of clinical target volumes (CTV) (12) (13) (14) . Malignant tumor cells that are dormant within or near the surgical bed may influence treatment outcomes. To our knowledge, no previous documentation has reported on the relationship between FC and LR in STS.
Though it is highly likely for small FC to be completely covered within the irradiation field without additional modifications, large FC will require a more extensive expansion of CTVs (Fig. 1) . A discussion with the surgeon on the likelihood of residual macro-or microscopic disease may be needed before deciding whether to include the fluid volume in the CTV. Currently, there are no precedent data to assist radiation oncologists in this decision-making process. This study is a novel analysis of PORT outcomes and post-treatment complications in the presence of FC after wide excision of STS.
Materials and methods

Study population
From 2004 to 2016, 256 patients with histologically confirmed STS were curatively treated with wide excision and PORT. Patients diagnosed with primary STS of any stage with no evidence of distant metastasis (DM) at the time of diagnosis were included for analysis. The following patients were excluded from the study: 43 patients with recurrent STS, 11 patients that had incomplete surgical excision, nine patients who did not fully complete their intended PORT course due to either personal choice or poor performance status, nine patients diagnosed with other malignancy, and four patients that received preoperative radiotherapy. Medical records of a final 180 patients were retrospectively reviewed, as approved by the Institutional Review Board, for all available data regarding patient, tumor and treatment characteristics with a median follow-up duration of 4.3 years (range 0.7-11.0). Histologic grades were evaluated according to the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grading system (15) and pathologic tumor staging was done according to the American Joint Committee on Cancer seventh edition (16) . Treatment-related complications were evaluated using the Common Terminology Criteria for Adverse Events version 4.0 (17).
Differentiation of fluid collection
Planning computed tomography (CT) and magnetic resonance (MR) images taken at the time of radiotherapy simulation were evaluated for the presence of FC. Though FC are typically homogeneously well-defined with low to intermediate signal intensity (SI) rim enhancement on contrast-enhanced T1-weighted MR and high SI on T2-weighted MR,~25% show atypical radiological appearances that need differential diagnosis with tumor recurrence (5, 7, 8, 18, 19) . The differentiation of radiologic findings between FC and potential tumor recurrence was assessed by trained radiologists.
FC was detected in 61 patients (33.9%), of which the most common site was the lower extremity (72.1%). Because the lower extremity was the predominant site being referred to our department (n = 88, 48.9%), only these patients were included for further analysis to reduce potential selection bias. General clinicopathologic characteristics of the study population are described in Supplementary Table 1 .
Statistical analysis
The primary endpoints were LC, overall survival (OS) and toxicity. Time intervals were calculated from the base of follow-up, defined as the date of wide excision, until the occurrence of events: LR, regional recurrence (RR), DM or death. The time interval between surgery and PORT was measured as weeks from the date of wide excision to the date of PORT initiation.
Univariate descriptive analyses were performed with an independent samples t-test for continuous variables and chi-squared test for categorical variables. Factors were evaluated for prognostic value using logistic regression and Cox proportional hazards model to estimate the odds ratio (OR) with a 95% confidence interval (CI). Factors with statistical significance on univariate analysis or considered to have clinical significance were included in multivariate analysis for covariate adjustment. LC and OS rates were calculated and compared using the Kaplan-Meier method and log-rank test.
All statistical analyses were performed using IBM SPSS Statistics version 22.0 (IBM Corp., Armonk, NY, USA). Statistical significance was defined as P < 0.05 with a two-tail approach.
Results
Clinicopathologic and treatment characteristics
Eighty-eight patients had lower extremity STS (LE-STS), of which 45 patients (51.1%) had FC. There were no significant differences in clinicopathologic and treatment characteristics according to the presence of FC (Table 1) . After wide excision with adequate resection margins, five patients had residual microscopic tumor involving adjacent nerves or tendons.
All patients were treated using three-dimensional conformal radiotherapy. PORT was prescribed with a median dose of 61.2 Gy (range 54-63) and 63 Gy (range 61.2-63) for patients with and without FC, respectively. The daily radiation dose was 1.8 Gy per fraction, given consecutively five times each week. Field reduction was done for all but two patients, both of whom had FC. The median total dose given to the large field and reduced field was 52.2 Gy (range 45-63) and 9 Gy (range 0-18), respectively, for patients with FC, and 45 Gy (range 45-54) and 16.2 Gy (range 7.2-18) for patients without FC.
Gross tumor volume (GTV) was defined as the postoperative surgical bed, including any residual microscopic tumor if present. CTVs were defined as areas of clinical suspicion, expanded from the GTV and modified to exclude anatomical boundaries. The median superiorinferior expansion was 5 cm (range 1-5) for the large field and 2.5 cm (range 0.5-3) for the reduced field. For the planning target volume (PTV), a median margin of 0.5 cm (0.3-1 cm) was added to the CTVs.
Development of fluid collection
Clinicopathologic characteristics were evaluated for prognostic value in the development of FC. Neither tumor size nor depth showed independent statistical significance, however, patients with tumors both >5 cm and deeply seated (pT2b) were associated with higher risk of developing FC (P = 0.019). Univariate analyses also demonstrated increased risk of FC with a FNCLCC differentiation score of 3 (P = 0.014). Both parameters retained statistical significance on multivariate analyses with a 2.9 OR for pT2b (95% CI 1.2-7.2, P = 0.021) and a 3.7 OR for FNCLCC differentiation score of 3 (95% CI 1.3-10.4, P = 0.015).
Management of fluid collection
Management of FC was done for 3 (6.7%) of 45 patients. Needle aspiration was done three times before and during PORT for the first patient, two sequential needle aspirations were done after PORT for the second patient, and hematoma evacuation was done before PORT for the third patient. The two patients that underwent management before PORT had residual FC at the time of PORT planning.
Coverage of fluid collection in the PORT field
The decision to include the FC volume as part of the GTV or CTV was decided upon at the discretion of the radiation oncologist and varied for each patient. Thus, coverage of the FC was compared based on the percentage of inclusion in the final PTV. FC coverage was defined as complete if 100% of the volume was included and partial if otherwise. The FC was completely covered in the PTV throughout the full course of PORT for 36 patients (80.0%). Of the nine patients that had partial coverage, one patient had partial coverage of FC in both large field (PTV LF ) and reduced field PTV (PTV RF ). Eight patients had complete coverage in PTV LF , but partial coverage in PTV RF .
Patterns of failure
Among the 88 patients with LE-STS, 29 patients (33.0%) had tumor recurrence. Twenty-six patients (29.5%) had DM, of which lung metastasis was the most common. Eleven patients (12.5%) had LR-where nine patients showed in-field recurrence-and five patients (5.7%) had RR.
Though there was no statistical difference between patterns of failure regarding FC, patients with FC had comparatively more LR (Fig. 2) . Of the eight patients with LR in the FC group, six patients had recurred tumors at or ≤4 cm from the FC wall (Table 2) . A case example is given in Fig. 3 . This patient had received 45 Gy to the large field and an additional 16.2 Gy to the reduced field with conventional fractionation. Though full fluid collection volume was included in the CTV of the large field, only partial volumes of the fluid collection that overlapped areas of the tumor bed was covered in the reduced field. In patients that recurred in out-of-field areas, three patients had recurred tumors at or ≤4 cm from the FC wall (patients 5, 6 and 8 in Table 2 ).
The median time-to-recurrence was shorter in patients with FC than those without-3.5 years (range 0.2-10.8) compared with 4.3 years (range 0.3-11.0) (P = 0.077). Patients with and without FC, respectively, had 5-year LC rates of 77.7% and 90.8% (P = 0.105) and 5-year OS rates of 83.0% and 82.0% (P = 0.476). There was no significant difference of 5-year LC rates between patients with complete and partial PTV coverage throughout the full course of PORT.
Post-treatment complications
Fourteen patients (15.9%) developed post-treatment complications: nine wound-related, three prosthesis-related, one joint stiffness, and one fracture. FC did not have significant correlation with the onset of complications. Wound complications occurred after PORT in 3 (6.7%) of 45 patients with FC and in 1 (2.3%) of 43 patients without FC, of which all were Grade 2. 
Discussion
Patients with FC after wide excision of LE-STS have higher rates of LR, particularly near the FC wall. Our study is the first to address the correlation between FC and PORT outcomes. Based on comparably low wound complication rates, we suggest the necessity and feasibility of including the entire extent of FC in the irradiation field in order not to compromise LC. FC develops more commonly in LE-STS, which may be due to gravitational effects-where fluid is more likely to pool in the lower extremity-and relatively smaller amounts of subcutaneous fat in the upper extremity (4, 7) . Currently, there is no consensus on whether or not FC should be covered in the CTV. Here we present three hypothetical explanations for the increased rate of LR with FC, and why full coverage of this volume in the PTV should be considered.
Firstly, FC may host dormant tumor cells. Pathologic studies have shown that microscopic tumor spread of STS can exist up to 4 cm beyond the surgical bed despite excision with adequate margins (10, 11) . Though the correlation between microscopic tumor cell behavior and FC is unclear for STS, malignant cytology in seroma after breast cancer surgery has been documented in a small number of studies. In one of the earliest studies, Vujičić et al. (20) analyzed breast seroma drainage samples of 142 patients and reported tumor cells in the samples of 32 patients (22.5%). Though the likelihood of surgical field contamination was not clearly investigated, this preliminary study proposed a potential link between FC and microscopic tumor. A recent prospective study of 68 breast cancer patients examined samples of both seroma and surgical field irrigation (21) . After adequate irrigation with normal saline, these samples were collected to assess for surgical field contamination. Seroma drainage samples were collected 48 h after surgery. Tumor cells were identified in seroma samples of four patients (5.9%) and all irrigation samples were free of malignant cytology, confirming that these findings were not a result of surgical contamination. Based on such data, the potential presence of dormant tumor cells in FC volumes and ensuing questioning of its influence on local tumor recurrence seems a legitimate issue to consider.
Secondly, the presence of FC may cause increased tissue hypoxia. Compared with patients without FC, those with FC showed decreased LC rates and higher in-field LR. Hypoxic cells may have a potential role. Tumors with large regions of hypoxia are clinically associated with poor treatment outcomes due to its decreased sensitivity to ionizing radiation (22) (23) (24) . In patients with STS, this may be attributed to an increased probability of oxygenation compromise due to extensive resection of soft tissues and consequent transections of vasculature, which may result in dead spaces where fluid can accumulate. Fluid leakage into empty surgical cavities arises due to hydrostatic pressure, where in a normal condition would lead to increase of interstitial fluid pressure and tissue edema (25, 26) . The tumor microenvironment at the site of excision has impaired neoangiogenic functions and therefore the supply of oxygen and nutrients for any remnant viable tumor cell would be insufficient, leading to decreased sensitivity of tumor cells to radiation effects. From an analogous viewpoint, the presence of FC along the surgical bed may further decrease oxygenation. In tissues with edema from excessive interstitial fluid accumulation, increased distances are generally needed for oxygen diffusion, making these tissues potentially more prone to hypoxia and less sensitive to radiation (26) (27) (28) . Based on this concept for fluid that accumulates in interstitial spaces, postoperative collection of fluid into surgical cavities may similarly increase the potential for hypoxia. Thirdly, pressure-induced ischemia and migration of tumor cells may be associated with recurrence near FC. Extremity STS are generally limited within anatomical boundaries and surgical excision does not include neighboring fascial compartments unless otherwise involved. Resected tissues are closed layer-by-layer, where most FC occur between fascia and subcutaneous fat (5, 7) . Extensive volumes of FC may cause buildup of pressure by 'pushing against' adjacent tissues in enclosed muscle spaces. In our series, five of the six patients with LR near the FC wall had extensive FC larger than the initial tumor. LE-STS that are deep-seated may be particularly prone to higher intracompartmental pressures. A study questioning the relationship between internal tissue strain and pressure-related deep tissue injury-defined as muscle damage due to prolonged mechanical loads-suggested that increased strain leads to increased tissue damage and oxygen deprivation (29) . Kao et al. (30, 31) suggested in two related studies using lung cancer models that higher interstitial fluid pressure increases the invasiveness and migration speed of cancer cells. On this basis, radiosensitivity may decrease due to pressure-related hypoxic conditions and if any viable tumor cell is present in the FC or tissues at the resection margin, risk of LR may increase. Though inadequate to make a clear conclusion, we may be able to hypothesize increased interstitial fluid pressure in the presence of FC based on the likelihood of acute tissue edema, which is not uncommon after limb-sparing surgery.
In an era where reducing normal tissue toxicity is a key issue, the presence of extensive FC brings dilemma. Our results demonstrate that FC does not significantly increase post-PORT wound complications, which was reasonably low compared with previous data of similar cohorts (Table 3) (32) (33) (34) (35) (36) . Though further studies will be needed for support, we propose that it is feasible to fully include FC in the irradiation field without increasing the risk of wound complications.
As a single institution retrospective review, our series has several limitations such as a small sample size, possible selection bias, heterogeneity of target volume definition and dose prescription, and lack of a control group to compare FC coverage in irradiation fields. The FC was completely or partially included in the irradiation field for all patients, of which all partial coverage was >50%. Thus, proper comparison of PORT outcomes when FC was not covered could not be analyzed.
In conclusion, the presence of FC in the surgical bed is a potential risk factor for increased LR after limb-sparing wide excision and PORT in LE-STS, with most tumors recurring near the FC wall. Based on the comparably low rates of post-PORT wound complications, we suggest the need and feasibility of fully including FC volumes in the irradiation field. No previous study has evaluated the impact of FC in STS-our results could become a stepping stone for more in-depth investigation of FC concerning malignant cytology and treatment outcomes.
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